Epileptic spasms: experience with a high-dose oral corticosteroid protocol

Tyson L Ware1, Mark T Mackay, A Simon Harvey

  • 1Department of Neurology, Parkville University of Melbourne, Melbourne, Victoria, Australia.

Insights

High-dose oral prednisolone is effective for infantile epileptic spasms, showing high remission rates in non-tuberous sclerosis complex (TSC) infants. Vigabatrin was less effective in TSC patients, suggesting early steroid therapy consideration.

Area of Science:

  • Pediatric Neurology
  • Clinical Practice Audit

Background:

  • Infantile epileptic spasms (IES) require effective treatment protocols.
  • Assessing adherence to and outcomes of a new IES treatment protocol was needed.

Purpose of the Study:

  • To audit clinical practice for infantile epileptic spasms.
  • To assess early outcomes of infants treated with an agreed initial treatment protocol.

Main Methods:

  • Retrospective review of 28 infants diagnosed with epileptic spasms between July 2007 and June 2009.
  • Assessed adherence to a protocol using high-dose oral prednisolone (or vigabatrin for tuberous sclerosis complex - TSC) and evaluated remission by day 14, recurrence, and side effects.

Main Results:

  • 100% remission by day 14 in cryptogenic IES treated per protocol.
  • 64% remission in non-TSC symptomatic IES treated per protocol vs. 20% not per protocol.
  • 17% remission in TSC infants treated with vigabatrin per protocol.

Conclusions:

  • High-dose oral prednisolone is effective and tolerable for infantile epileptic spasms.
  • The protocol supports high-dose oral prednisolone as a treatment of choice for non-TSC symptomatic IES.
  • Early consideration of steroid therapy is warranted given poor vigabatrin response in TSC.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...